STOCK TITAN

RXRX (NASDAQ: RXRX) Rule 144 filing plans 40,000 Class A share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Christopher C. Gibson has filed a Rule 144 notice to sell 40,000 shares of Class A stock through Fidelity Brokerage Services LLC on the NASDAQ, with an approximate aggregate market value of $178,800 and an expected sale date of 01/20/2026. The filing reports that these 40,000 shares were acquired on 09/01/2016 as founders shares from the issuer as compensation. The notice lists 514,895,802 shares of this class outstanding. Over the prior three months, Gibson reported multiple sales of Class A shares, including 100,000 shares on 10/23/2025 for gross proceeds of $570,000 and separate 40,000‑share transactions on 11/04/2025, 11/19/2025, 12/04/2025, 12/19/2025, and 01/05/2026, with individual gross proceeds ranging from $166,400 to $208,400.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many RXRX Class A shares are planned to be sold under this Rule 144 notice?

The notice covers a proposed sale of 40,000 shares of Class A stock.

What is the approximate market value of the RXRX shares to be sold?

The filing lists an aggregate market value of $178,800 for the 40,000 Class A shares.

When are the RXRX shares expected to be sold and on which exchange?

The approximate date of sale is 01/20/2026, and the shares are to be sold on the NASDAQ.

How and when did Christopher C. Gibson acquire the RXRX shares covered by this notice?

He acquired 40,000 Class A shares on 09/01/2016 as founders shares from the issuer, described as compensation.

What RXRX share sales has Christopher C. Gibson reported in the past three months?

The notice lists sales of 100,000 Class A shares on 10/23/2025 and 40,000-share transactions on 11/04/2025, 11/19/2025, 12/04/2025, 12/19/2025, and 01/05/2026.

How many RXRX Class A shares are reported as outstanding in this filing?

The filing states that 514,895,802 shares of the relevant Class A securities were outstanding.

Which broker is handling the planned RXRX Rule 144 share sale?

The planned sale is to be executed through Fidelity Brokerage Services LLC at its Smithfield, Rhode Island address.
Recursion Pharmaceuticals, Inc.

NASDAQ:RXRX

RXRX Rankings

RXRX Latest News

RXRX Latest SEC Filings

RXRX Stock Data

2.43B
494.19M
4.74%
69.3%
28.42%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SALT LAKE CITY